Medidata Solutions Inc (MDSO_old)

Medidata Solutions, Inc. develops SaaS and data analytics solutions that support clinical research trials for life sciences worldwide. It provides solutions, such as medidata platform, data management, trial management, patient engagement, professional services, evidence generation, healthcare solutions, and decentralized trials. The company offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies; Medidata Detect, a centralized statistical monitoring solution; and Medidata Risk Management that supports sponsors and contract research organizations as they identify critical data and processes, associated risks, and implement mitigation strategies as defined within ICH E6 (R2). Its platform solutions include data capture and management, and trial planning and management. The company also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. In addition, it offers myMedidata, an intuitive platform for patients to enable flexible participation in clinical trials for new medicines and vaccines. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. Medidata Solutions, Inc. has strategic collaborations with Mapi Research Trust; and HealthVerity to expand the understanding of clinical trial populations for enhanced insights during and post-trial. The company was founded in 1999 and is based in New York, New York with additional offices across the world. As of October 28, 2019, Medidata Solutions, Inc. operates as a subsidiary of Dassault Systemes Americas Corp.